We are live on ! Find out more
ZEPP

Zepp Health
ZEPP

Fund managers haven’t disclosed any holdings of ZEPP yet.

ZEPP Hedge Fund Activity: Q1 2026 in Review

32 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q1 2026, worth a combined $41.3M — down 57% from $96.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ZEPP and 7 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 11 added.

The largest buyer was Morgan Stanley, adding an estimated $1.99M. The largest seller was Balyasny Asset Management, cutting an estimated $2.77M.

  • 32 institutional investors held Zepp Health (ZEPP) as of Q1 2026, down from 38 in Q4 2025.
  • Funds reported $41.3M of Zepp Health stock for Q1 2026, down 57% quarter-over-quarter.
  • 7 funds opened new Zepp Health positions in Q1 2026 and 13 closed out, a net change of -6 holders.
  • The largest Zepp Health buyer in Q1 2026 was Morgan Stanley, an estimated $1.99M added.
  • The largest Zepp Health seller in Q1 2026 was Balyasny Asset Management, an estimated $2.77M sold.

Based on aggregated 13F filings for Q1 2026.